30 November 2020
Dutch clinic prescribes remote monitoring to 777 heart patients during the COVID-19 pandemic
FibriCheck enables large scale teleconsultations at Maastricht University Medical Centre+
8 October 2020
FibriCheck now available for Samsung Galaxy Watch3, delivering life-saving technology to thousands of smartwatch users
The CE-marked FibriCheck app is now available for download from the Samsung Galaxy Store for the recently launched Samsung Galaxy Watch3, demonstrating the technology’s true cross-platform compatibility. The FibriCheck app that helps detect potentially debilitating heart rhythm irregularities such as…
8 June 2020
First step towards the Asia-Pacific region
FibriCheck gains approval from Australia’s Therapeutic Goods Administration (TGA) FibriCheck, the mobile app capable of detecting heart rhythm disorders, was granted an Australian Register of Therapeutic Goods Certificate by the Australian Government Department of Health last week. As the first…
3 June 2020
FibriCheck guards you while you sleep
Night monitoring now closer than ever after successful beta test If you’re familiar with atrial fibrillation, you’ll know it can be a dangerous condition – the heart rhythm disorder is responsible for around 25% of all strokes1. You’ll also know…
22 April 2020
Guaranteeing continuity of care during the lockdown and beyond
TeleCheck-AF remote screening project goes live across Europe It’s no secret the COVID-19 pandemic is placing enormous pressure on our healthcare system. Capacity in our hospitals and clinics is stretched thin. And some patients may find it hard to get…
30 March 2020
FibriCheck’s new medical smartwatch app gives smartwatch manufacturers a competitive edge
A world first - FibriCheck app automatically detects both silent and intermittent atrial fibrillation at night, dramatically reducing the risk of stroke in 40-plussers Hasselt, Belgium, 31 March 2020 - FibriCheck, the first CE- and FDA-approved medical app, today announces…
FibriCheck selected to join the NHS Innovation Accelerator
FibriCheck has been announced as one of 11 innovations selected to join the award-winning NHS Innovation Accelerator (NIA) in 2020 FibriCheck is thrilled to be among the new innovations joining the 2020 NIA programme. FibriCheck is an innovative, hardware-free…
What is atrial fibrillation?
Atrial fibrillation or AF is the most common heart rhythm disorder and is defined by its irregular and often accelerated heart beat. Untreated atrial fibrillation increases the chance for certain serious disorders like stroke, heart failure, diabetes, dementia and hypertension.…